The value of eosinophilic cationic protein in atopic dermatitis
DOI:
https://doi.org/10.66344/jpad.v31i3.1695Abstract
Objective Till date, the search for diagnostic markers of atopic dermatitis (AD) is still active. Such investigations will assess not only the allergic inflammation, but also help controlling the severity of the disease.
Method To analyze diagnostic significance of eosinophilic cationic protein in AD patients, a number of 24 patients with AD and 10 practically healthy persons were examined. The patients in the main study group were distributed by age: 18-40 years (12 persons) and over 40 years (12 persons). All AD patients were tested for allergic inflammation makers. Statistical processing of the obtained results was carried out by the method of variational statistics using the Statistica 10.
Results With ageing, there was a tendency to a decreased number of AD extrinsic (high levels of IgE), instead the number of people with AD intrinsic increased (low levels of IgE) (OR = 2.92; 95% CI 1.83-4.65; p <0.001). In addition, both the forms of AD and the total serum IgE level were dependent on the age of the patients (OR = 5.72, 95% CI [2.52–13.94]; p <0.001). Simultaneously, when the severity of AD increased, ECP levels were increased significantly (OR = 4.26, 95% CI [2.01–9.05)].
Conclusion It is efficient to determine the level of ECP in AD, as an indicator for allergic inflammation. The levels of ECP increased with the severity of the disease. The level of ECP did not depend on the age of the patient and the form of AD.
References
1. Kowalska-Olędzka E, Czarnecka M, Baran A. Comparison of treatment standards in Atopic Dermatitis management across selected geographies prior to emerging targeted therapies onset. J Drug Assess. 2019;8(1):122–125. https://doi.org/10.1080/21556660.2019.1619569.
2. Eichenfield LF, Ahluwalia J, Waldman A, Borok J, Udkoff J, Boguniewicz M. Current guidelines for the evaluation and management of atopic dermatitis: a comparison of the joint task force practice parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol.2017;139(4S):49–57. https://doi.org/10.1016/j.jaci.2017.01.009.
3. Rutkowski K, Sowa P, Rutkowska-Talipska J, Sulkowski S, Rutkowski R. Allergic diseases: the price of civilisational progress. Postepy Dermatol Alergol.2014;31(2):77–83. https://doi.org/10.5114/pdia.2014.40936.
4. Jaworek AK, Szafraniec K, Jaworek M, Hałubiec P, Wojas-Pelc A. The level of total immunoglobulin E as an indicator of disease grade in adults with severe atopic dermatitis. Pol Merkur Lekarski.2019;47(282):217–220. http://pml.medpress.com.pl/ePUBLI/free/PML282-217.pdf. Accessed: July 27, 2020.
5. Mulick AR, Allen V, Williams HC, et al. Classifying atopic dermatitis: protocol for a systematic review of subtypes (phenotypes) and associated characteristics. BMJ Open. 2018;8(9):e023097. https://doi.org/10.1136/bmjopen-2018-023097.
6. Lee JM, Jin HJ, Noh G, Lee SS. Effect of processed foods on serum levels of eosinophil cationic protein among children with atopic dermatitis. Nutr Res Pract. 2011; 5(3):224–229. https://doi.org/10.4162/nrp.2011.5.3.224.
7. Park SY, Oh S, Kim EJ, et al. Utility of eosinophil cationic protein levels in the diagnosis of intrinsic atopic dermatitis. Acta Derm Venereol. 2014;94:333–4. https://doi.org/10.2340/00015555-1715.
8. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh).1980;60(92):44–47. https://doi.org/10.2340/00015555924447.
9. Slobodna M‐S, Jasna L, Vesna Ž, Karmela H, Branka M. Serum eosinophil cationic protein in children with atopic dermatitis. Int J Dermatol.2006;45(10):1156–60. https://doi.org/10.1111/j.1365-4632.2006.02865.x.
10. Byeon JH, Yoon W, Ahn SH, Lee HS, Kim S, Yoo Y. Correlation of serum interleukin-31 with pruritus and blood eosinophil markers in children with atopic dermatitis. Allergy Asthma Proc. 2020;41(1):59–65. https://doi.org/10.2500/aap.2020.41.190016.
11. Angelova‐Fischer I, Hipler UC, Bauer A, et al. Significance of interleukin‐16, macrophage‐derived chemokine, eosinophil cationic protein and soluble E‐selectin in reflecting disease activity of atopic dermatitis – from laboratory parameters to clinical scores. Br J Dermatol. 2006;154(6):1112–7. https://doi.org/10.1111/j.1365-2133.2006.07201.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Sergiy, Nadia , Ehab , Yulia , Vitaliy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
